Rare diseases
Investigational molecules
Locations
Back to Germany357 clinical trials in Mannheim, Germany across 2 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in GermanyKlinischeStudien.de(opens in a new tab)Study of oral BI 1815368 compared to placebo in patients with diabetic macular edema over 48 weeks of treatment
GermanyStudy of ivosidenib maintenance treatment in patients with IDH1-mutated cholangiocarcinoma after standard chemotherapy
GermanyStudy of deupsilocin besilate (CYB003) in adults with major depressive disorder comparing two doses against placebo
GermanyStudy of drug combination therapy for prevention of recurrent stroke in patients with acute ischemic stroke and atrial fibrillation
GermanyStudy of Dapagliflozin for Reducing Cardiovascular Events in Adults with High Blood Pressure
GermanyStudy of trastuzumab deruxtecan with bevacizumab versus bevacizumab alone as first-line maintenance treatment for patients with HER2-expressing ovarian cancer
GermanyStudy of VHB937 to evaluate its effects on cognition and function in people with early Alzheimer's Disease over 72 weeks
GermanyStudy of datopotamab deruxtecan with platinum-based therapy compared to gemcitabine with platinum-based therapy in patients with advanced urothelial cancer after prior treatment
GermanyLong-term safety and effectiveness study of CYB003 (deupsilocin besilate) with optional additional doses for people with Major Depressive Disorder
GermanyEvaluating the Effect of Vicadrostat and Empagliflozin Combination Compared to Empagliflozin Alone in Patients with Heart Failure and Reduced Left Ventricular Function
GermanyStudy of Trastuzumab Deruxtecan, Rilvegostomig, and Pembrolizumab for Advanced or Recurrent Endometrial Cancer in HER2-Positive Patients
GermanyComparison of TAK-881 and HyQvia for adults with chronic inflammatory demyelinating polyradiculoneuropathy (CIDP)
GermanyThe busiest research cities in the country
What the registry says about research in the country
Clinical investigations focusing on Alzheimer's Disease and ALS, including trials of new therapeutic compounds for early-stage dementia and innovative treatments for motor neuron disease.
Research aims to improve brain amyloid clearance and evaluate new treatment approaches for neurological disorders.
Comprehensive studies in cancer treatment, including trials for gastric cancer, melanoma, and breast cancer, with a focus on targeted therapies and immunological approaches.
Advanced treatments combining immunotherapy with established protocols to improve patient outcomes.
Studies addressing inflammatory disorders, particularly focusing on Crohn's Disease, ulcerative colitis, and uveitis, testing novel therapeutic combinations.
Innovative treatment strategies aimed at improving disease management and patient quality of life.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
